The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.00
Bid: 52.00
Ask: 54.00
Change: -0.40 (-0.75%)
Spread: 2.00 (3.846%)
Open: 53.00
High: 53.00
Low: 52.50
Prev. Close: 53.40
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding and Total Voting Rights

7 Nov 2023 07:00

RNS Number : 5558S
SDI Group PLC
07 November 2023
 

SDI Group plc

("SDI", the "Company", or the "Group")

 

Director/PDMR Shareholding, Exercise of Share Options and Total Voting Rights

 

SDI Group plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications, announces that it has been notified that Mike Creedon, Chief Executive Officer, has purchased 42,606 shares at an weighted average price of 116 pence.

Further to the above, the Company also announces that it has issued and allotted a total of 30,000 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following an exercise of options by a non PDMR employee.

Application has been made to the London Stock Exchange for the 30,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8:00 a.m. on or around 10 November 2023.

Following Admission, the total number of Ordinary Shares in issue will be 104,080,044 and the total number of voting rights will therefore be 104,080,044. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Following the purchase and Admission, Mike Creedon will hold 393,978 Ordinary Shares, representing 0.38% of the total issued share capital.

 

Enquiries

 

SDI Group plc

Mike Creedon, CEO  01223 727144

Ami Sharma, CFO

www.sdigroup.com

 

Cavendish Capital Markets Limited 020 7220 0500

Ed Frisby/Seamus Fricker - Corporate Finance

Andrew Burdis/Sunila de Silva - ECM

 

 

About SDI Group plc:

 

SDI designs and manufactures scientific and technology products for use in digital imaging and sensing and control applications including life sciences, healthcare, astronomy, plastics and packaging, manufacturing, precision optics, measurement instrumentation and art conservation. SDI operates through its subsidiaries: Atik Cameras, Synoptics, Graticules Optics, Sentek, Astles Control Systems, Applied Thermal Control, MPB Industries, Chell Instruments, Monmouth Scientific, Uniform Engineering, Scientific Vacuum Systems, Safelab Systems, LTE Scientific, Fraser Anti-Static Techniques and Peak Sensors.

SDI continues to grow by developing its own technology advancements and by improving its global sales channels, as well as through pursuing strategic, complementary acquisitions.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mike Creedon

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SDI Group plc

b)

LEI

213800YA3XW7JRE46Z70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B3FBWW43

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Purchase of Ordinary Shares

117 pence

12,606

Purchase of Ordinary Shares

115 pence

30,000

 

d)

Aggregated information:

·Aggregated volume

·Price

 

42,606

Weighted average price of 116 pence

e)

Date of the transaction

6 November 2023

f)

Place of the transaction

Purchase at 117 pence - London Stock Exchange (AIM - XLON)

Purchase at 115 pence - Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFSUFAMEDSEEF
Date   Source Headline
12th Dec 20127:00 amRNSUnaudited Interim Results to 31 October 2012
12th Dec 20127:00 amRNSSynoptics Health: ProReveal product launch update
15th Nov 20124:59 pmRNSHolding(s) in Company
16th Oct 20127:00 amRNSIssue of Equity
11th Sep 20123:20 pmRNSResult of AGM
25th Jul 201212:01 pmRNSDirector/PDMR Shareholding
25th Jul 20128:12 amRNSFinal Results
29th May 201210:05 amRNSDirectorate Change
16th Dec 20117:00 amRNSHalf Yearly Report
15th Sep 20111:52 pmRNSAppointment of Acting Managing Director
1st Sep 20112:04 pmRNSResult of AGM
18th Jul 20115:01 pmRNSNotice of Results
1st Jun 20111:00 pmRNSTrading Update
17th Jan 20117:00 amRNSHalf Yearly Report
10th Dec 20103:48 pmRNSTrading Update
27th Sep 201012:01 pmRNSSector Change
23rd Sep 20103:15 pmRNSResult of AGM
19th Jul 20102:27 pmRNSDirector/PDMR Shareholding
19th Jul 20107:00 amRNSFinal Results
16th Jul 20108:58 amRNSAnalyst Presentation
7th Jul 201012:08 pmRNSNotice of Results
7th Jul 201012:01 pmRNSChange of Adviser
28th Jun 20107:00 amRNSSynbiosis Update
24th May 20107:00 amRNSDirectorate Change
21st May 20107:00 amRNSTrading Update
16th Mar 201012:25 pmRNSDirectorate Changes
2nd Mar 20109:59 amRNSTrading Update
10th Feb 20107:00 amRNSNew Atik Camera
25th Jan 20107:00 amRNSHalf Yearly Report
4th Jan 20104:20 pmRNSDirectorate Change
9th Dec 20091:46 pmRNS12 Months on AIM
21st Oct 200911:21 amRNSResult of AGM
16th Oct 20093:45 pmRNSIssue of Equity
14th Oct 20094:50 pmRNSChange of Adviser
14th Sep 20097:00 amRNSFinal Results
18th Jun 20094:52 pmRNSExercise of Options
7th Apr 20097:00 amRNSTrading Statement
6th Feb 20094:14 pmRNSDirector/PDMR Shareholding
27th Jan 20097:30 amRNSInterim Results
8th Dec 20087:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.